During a live surgical webcast originating at Springhill Medical Center, gynecologic surgeons from all over the world will have the unique opportunity to view a hysteroscopic myomectomy, featuring the ...
HOLX's GYN Surgical unit, boosted by MyoSure, Fluent and Gynesonics, drives 10.2% revenue growth and is likely to lift ...
MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ -- Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ® MANUAL device, which was designed to simplify tissue removal procedures ...
Hologic, Inc. HOLX recently announced the launch of new Fluent fluid management system in the United States. Per the company, this system is embedded with features that simplify and improvise the ...
Hologic has agreed to pay $125 million to acquire privately held Interlace. The company makes the MyoSure hysteroscopic tissue removal system that helps easily remove fibroids and polyps. Hologic, a ...
In line with Hologic, Inc. 's HOLX focus to grow within the promising space of GYN Surgical, it recently came up with a significant breakthrough. The company has made the U.S. launch of its Omni ...
Doha: Al-Ahli Hospital uses modern technology to remove fibroids, benign tumors, and other tissues without removing the uterus. Dr. Mazen Bishtawi, obstetrician and gynecologist consultant, said: “The ...
--Designed to Simplify Intrauterine Tissue Removal In Theater and In-Office-- MARLBOROUGH, Massachusetts, Jan. 3, 2018 /PRNewswire/ --Hologic, Inc. (Nasdaq: HOLX) announced today that the MyoSure ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results